The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 2, 2002, Pages 497-503

  Nuyttens, Joost J ^a,b   Robertson, John M ^a,c   Yan, Di ^a   Martinez, Alvaro ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c NONE   (United States)

Author keywords

CTV; Organ motion; Rectal cancer

Indexed keywords

BLOOD; BONE; COMPUTERIZED TOMOGRAPHY; MUSCLE; PATIENT TREATMENT; PLANNING; RADIOTHERAPY;

CLINICAL TARGET VOLUME (CTV);

ONCOLOGY;

ARTICLE; BLADDER CAPACITY; BLOOD VESSEL; CALCULATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MUSCLE; PELVIC GIRDLE; PRIORITY JOURNAL; RECTUM CARCINOMA; TREATMENT PLANNING; TUMOR VOLUME;

FEMALE; HUMANS; MALE; MOVEMENT; PELVIS; PHYSICS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RECTUM; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER; URINE;

EID: 0036603603     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02753-0     Document Type: Article

References (37)

1. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
2. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: A progress report of the National Surgical Adjuvant Breast and Bowel Project Protocol R-03
3. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer
4. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of Intergroup 0114
5. Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma
6. Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer: An overview
7. Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer
8. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation
9. Volumetric analysis of small bowel displacement from radiation portals with the use of a pelvic tissue expander
10. A CT-based analysis of the relationship between acute grade 3 small bowel toxicity and the volume of small bowel irradiated in patients receiving concurrent chemoradiotherapy for rectal cancer
11. Treatment planning for colorectal cancer: Radiation and surgical techniques and value of small-bowel films
12. Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum: Clinicopathologic correlation and implications for adjuvant therapy
13. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation
14. Patterns of recurrence of rectal cancer after potentially curative surgery
15. Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer
16. Preoperative radiochemotherapy in rectal cancer: Long-term results of a Phase II trial
17. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
18. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
19. The potential benefit of intensity modulated radiation therapy (IMRT) for rectal cancer
20. The small bowel position during adjuvant radiation therapy for rectal cancer
21. Colon, and rectum
22. Location of pelvic recurrence after 'curative' low anterior resection for rectal cancer
23. Patterns of pelvic recurrence following definitive resections of rectal cancer
24. Pathological evidence in support of total mesorectal excision in the management of rectal cancer
25. Local recurrence after curative resection of cancer of the rectum without total mesorectal excision
26. Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method
27. Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method
28. Total mesorectal excision and local recurrence: A study of tumour spread in the mesorectum distal to rectal cancer
29. Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: Implications in treatment planning with adjuvant radiation therapy
30. The lymphatic and venous spread of carcinoma of the rectum
31. Utility of mapping lymph nodes cleared from rectal adenocarcinoma specimens
32. Analysis of regional lymph node metastases from rectal carcinoma by the clearing method: Justification of the use of sigmoid in J-pouch construction after low anterior resection
33. Normal anatomy
34. Lymphographic roentgen anatomy
35. Quantification of organ motion during conformal radiotherapy of the prostate by three-dimensional image registration
36. Treatment planning for colorectal cancer: Radiation and surgical techniques and value of small-bowel films
37. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer